Ignite Creation Date:
2024-05-06 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03599713
Status:
COMPLETED
Last Update Posted:
2024-04-11
First Post:
2018-07-16
Brief Title:
A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma POD1UM-201
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Study Overview
Official Title:
A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma POD1UM-201
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with advancedmetastatic Merkel cell carcinoma MCC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None